180 related articles for article (PubMed ID: 20414716)
1. Postnatal development of neurons, interneurons and glial cells in the substantia nigra of mice.
Abe M; Kimoto H; Eto R; Sasaki T; Kato H; Kasahara J; Araki T
Cell Mol Neurobiol; 2010 Aug; 30(6):917-28. PubMed ID: 20414716
[TBL] [Abstract][Full Text] [Related]
2. Alterations of interneurons in the striatum and frontal cortex of mice during postnatal development.
Eto R; Abe M; Kimoto H; Imaoka E; Kato H; Kasahara J; Araki T
Int J Dev Neurosci; 2010 Aug; 28(5):359-70. PubMed ID: 20406674
[TBL] [Abstract][Full Text] [Related]
3. Alterations of glial cells in the mouse hippocampus during postnatal development.
Kimoto H; Eto R; Abe M; Kato H; Araki T
Cell Mol Neurobiol; 2009 Dec; 29(8):1181-9. PubMed ID: 19472050
[TBL] [Abstract][Full Text] [Related]
4. Cerebral alterations in a MPTP-mouse model of Parkinson's disease--an immunocytochemical study.
Muramatsu Y; Kurosaki R; Watanabe H; Michimata M; Matsubara M; Imai Y; Araki T
J Neural Transm (Vienna); 2003 Oct; 110(10):1129-44. PubMed ID: 14523625
[TBL] [Abstract][Full Text] [Related]
5. Age-related changes of NGF, BDNF, parvalbumin and neuronal nitric oxide synthase immunoreactivity in the mouse hippocampal CA1 sector.
Hayakawa N; Abe M; Eto R; Kato H; Araki T
Metab Brain Dis; 2008 Jun; 23(2):199-211. PubMed ID: 18421425
[TBL] [Abstract][Full Text] [Related]
6. Minor immunoreactivity in GDNF-, BDNF-, or NT-3-treated substantia nigra allografts.
Shinoda M; Hoffer BJ; Olson L
J Neural Transplant Plast; 1997; 6(2):83-96. PubMed ID: 9306240
[TBL] [Abstract][Full Text] [Related]
7. Effect of angiotensin-converting enzyme inhibitor perindopril on interneurons in MPTP-treated mice.
Kurosaki R; Muramatsu Y; Kato H; Watanabe Y; Imai Y; Itoyama Y; Araki T
Eur Neuropsychopharmacol; 2005 Jan; 15(1):57-67. PubMed ID: 15572274
[TBL] [Abstract][Full Text] [Related]
8. Protective effects of neuronal nitric oxide synthase inhibitor in mouse brain against MPTP neurotoxicity: an immunohistological study.
Watanabe H; Muramatsu Y; Kurosaki R; Michimata M; Matsubara M; Imai Y; Araki T
Eur Neuropsychopharmacol; 2004 Mar; 14(2):93-104. PubMed ID: 15013024
[TBL] [Abstract][Full Text] [Related]
9. Damage to neurons and oligodendrocytes in the hippocampal CA1 sector after transient focal ischemia in rats.
Uchida H; Fujita Y; Matsueda M; Umeda M; Matsuda S; Kato H; Kasahara J; Araki T
Cell Mol Neurobiol; 2010 Oct; 30(7):1125-34. PubMed ID: 20625811
[TBL] [Abstract][Full Text] [Related]
10. Role of inducible or neuronal nitric oxide synthase in neurogenesis of the dentate gyrus in aged mice.
Adachi M; Abe M; Sasaki T; Kato H; Kasahara J; Araki T
Metab Brain Dis; 2010 Dec; 25(4):419-24. PubMed ID: 21082337
[TBL] [Abstract][Full Text] [Related]
11. Expression of S-100 protein is related to neuronal damage in MPTP-treated mice.
Muramatsu Y; Kurosaki R; Watanabe H; Michimata M; Matsubara M; Imai Y; Araki T
Glia; 2003 May; 42(3):307-13. PubMed ID: 12673835
[TBL] [Abstract][Full Text] [Related]
12. GDNF is predominantly expressed in the PV+ neostriatal interneuronal ensemble in normal mouse and after injury of the nigrostriatal pathway.
Hidalgo-Figueroa M; Bonilla S; Gutiérrez F; Pascual A; López-Barneo J
J Neurosci; 2012 Jan; 32(3):864-72. PubMed ID: 22262884
[TBL] [Abstract][Full Text] [Related]
13. Telmisartan attenuates MPTP induced dopaminergic degeneration and motor dysfunction through regulation of α-synuclein and neurotrophic factors (BDNF and GDNF) expression in C57BL/6J mice.
Sathiya S; Ranju V; Kalaivani P; Priya RJ; Sumathy H; Sunil AG; Babu CS
Neuropharmacology; 2013 Oct; 73():98-110. PubMed ID: 23747572
[TBL] [Abstract][Full Text] [Related]
14. Protective action of neuronal nitric oxide synthase inhibitor in the MPTP mouse model of Parkinson's disease.
Watanabe Y; Kato H; Araki T
Metab Brain Dis; 2008 Mar; 23(1):51-69. PubMed ID: 18030609
[TBL] [Abstract][Full Text] [Related]
15. Brain-derived neurotrophic factor regulates early postnatal developmental cell death of dopamine neurons of the substantia nigra in vivo.
Oo TF; Marchionini DM; Yarygina O; O'Leary PD; Hughes RA; Kholodilov N; Burke RE
Mol Cell Neurosci; 2009 Aug; 41(4):440-7. PubMed ID: 19409492
[TBL] [Abstract][Full Text] [Related]
16. Role of dopamine transporter against MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity in mice.
Kurosaki R; Muramatsu Y; Watanabe H; Michimata M; Matsubara M; Imai Y; Araki T
Metab Brain Dis; 2003 Jun; 18(2):139-46. PubMed ID: 12822832
[TBL] [Abstract][Full Text] [Related]
17. Time dependent changes of striatal interneurons after focal cerebral ischemia in rats.
Sakuma M; Hyakawa N; Kato H; Araki T
J Neural Transm (Vienna); 2008; 115(3):413-22. PubMed ID: 18301954
[TBL] [Abstract][Full Text] [Related]
18. Substantia nigra dopaminergic neurons and striatal interneurons are engaged in three parallel but interdependent postnatal neurotrophic circuits.
Ortega-de San Luis C; Sanchez-Garcia MA; Nieto-Gonzalez JL; García-Junco-Clemente P; Montero-Sanchez A; Fernandez-Chacon R; Pascual A
Aging Cell; 2018 Oct; 17(5):e12821. PubMed ID: 30058223
[TBL] [Abstract][Full Text] [Related]
19. GFRalpha-1 mRNA in dopaminergic and nondopaminergic neurons in the substantia nigra and ventral tegmental area.
Sarabi A; Hoffer BJ; Olson L; Morales M
J Comp Neurol; 2001 Dec; 441(2):106-17. PubMed ID: 11745638
[TBL] [Abstract][Full Text] [Related]
20. Progenitor proliferation in the adult hippocampus and substantia nigra induced by glial cell line-derived neurotrophic factor.
Chen Y; Ai Y; Slevin JR; Maley BE; Gash DM
Exp Neurol; 2005 Nov; 196(1):87-95. PubMed ID: 16112112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
